Saince ("Company", "We", "Us", or "Our") respects your privacy. This Privacy Policy describes how we collect, use, and share information about you when you visit our websites www.saince.com or www.sainceprava.com or www.saincesara.com or www.sainceziva.com or www.doc-u-scribe.com (the "Sites") or interact with our marketing communications.
IMPORTANT: This policy applies to website visitors, prospective customers, and marketing leads.
- If you are a User of our Clinical Software: Your use is governed by our End User License Agreement (EULA) and the Business Associate Agreement (BAA) signed with your organization.
- Patient Data: We do not collect Protected Health Information (PHI) through this public website. Please do not submit patient data through our "Contact Us" forms.
1. INFORMATION WE COLLECT
We collect information in the following ways:
(a) Information You Voluntarily Provide:
- Contact Information: When you fill out forms to request a demo, subscribe to our newsletter, or contact support (e.g., Name, Email Address, Phone Number, Job Title, Organization Name).
- Communications: The content of any messages you send to us.
(b) Information Collected Automatically (Cookies & Analytics):
- Usage Data: Pages you visit, time spent on pages, clicks, and navigation patterns.
- Technical Data: IP address, browser type, device type, operating system, and approximate location (derived from IP).
- Cookies: We use cookies and pixel tags to track activity and improve your experience. You can control cookies through your browser settings.
2. HOW WE USE YOUR INFORMATION
We use your data for the following legitimate business purposes:
| Purpose |
Legal Basis (India DPDP Act 2023) |
Legal Basis (USA / GDPR) |
| To Provide Services: Fulfilling your request for a demo, whitepaper, or support. |
Legitimate Use (Voluntary Provision) (Sec 7) |
Performance of Contract / Legitimate Interest |
| Marketing & Communication: Sending newsletters, product updates, and promotional offers. |
Consent (Sec 6) |
Consent / Legitimate Interest |
| Website Improvement & Analytics: Analyzing traffic to optimize Site performance and user experience. |
Legitimate Use |
Legitimate Interest |
| Internal AI Training: Using anonymized inquiry data to train our internal sales and support AI models. |
Consent (via Privacy Notice) |
Legitimate Interest |
| Security: Detecting and preventing fraud or cyber threats. |
Legitimate Use |
Legitimate Interest |
3. CONSENT FOR MARKETING AND AI TRAINING
By checking the "I Agree" box on our forms or by continuing to use our Site after reviewing this policy:
- Marketing Consent: You explicitly consent to receive commercial communications from us via email or phone. You may withdraw this consent at any time by clicking "Unsubscribe" in our emails.
- AI & Product Improvement: You grant us permission to anonymize your personal data (removing direct identifiers like name/email) and use the resulting Anonymized Data to train our Artificial Intelligence (AI) and Machine Learning (ML) models for improving our products and customer experience. You acknowledge that Anonymized Data is no longer "Personal Data" under the DPDP Act.
4. SHARING OF INFORMATION
We do not sell your personal information. We may share it with:
- Service Providers: Third-party vendors who help us operate the Site, send emails, or analyze traffic (e.g., HubSpot, Google Analytics, AWS). They are contractually bound to protect your data.
- Legal Obligations: If required by law, court order, or government regulation (e.g., CERT-In in India).
- Business Transfers: In connection with a merger, acquisition, or sale of assets.
5. YOUR RIGHTS
A. For Visitors from India (DPDP Act 2023):
- Right to Access: Request a summary of your personal data being processed.
- Right to Correction/Erasure: Request correction of errors or deletion of your data (unless retention is required by law).
- Right to Grievance Redressal: Contact our Grievance Officer (details below).
- Right to Nominate: Nominate an individual to exercise your rights in case of death/incapacity.
B. For Visitors from the USA and Europe (California/CCPA & Others):
- Right to Know/Delete: Request disclosure of data collected or deletion of your data.
- Opt-Out: We do not "sell" data in the traditional sense, but you may opt out of sharing data for cross-context behavioral advertising (if applicable).
- Do Not Track: We honor Global Privacy Control (GPC) signals where required.
6. LIABILITY DISCLAIMER (WEBSITE CONTENT)
No Professional Advice: The content on this website (blogs, whitepapers, case studies) is for general informational purposes only. It does not constitute medical, legal, or professional compliance advice.
Accuracy: While we strive for accuracy, Saince makes no warranties, express or implied, regarding the accuracy, completeness, or reliability of the content.
Limitation of Liability: To the fullest extent permitted by law, Saince shall not be liable for any direct, indirect, incidental, or consequential damages arising from your use of this Site or reliance on any information provided herein.
7. CONTACT AND GRIEVANCE OFFICER (INDIA)
If you have questions about this policy or wish to exercise your rights, please contact:
USA:
- Name: Raghu Vir
- Email: raghu.vir@saince.com
- Address: Saince Inc 5490 McGinnis Village Place, Ste 116 Alpharetta GA 30005.
India:
- Name: Raghuvir Vedantham
- Designation: Grievance Officer
- Address: Email: raghu.vir@saince.com Address: Saince Healthtech Private Limited. 6-3-1090, Ground Floor, Block B TSR Towers, Rajbhavan Road, Somajiguda Hyderabad - 500082, Telangana India.
We will respond to grievances within the timeline prescribed by applicable law.
Common investors in the healthcare delivery industry have historically been difficult to track. One recent study published in Health Affairs Magazine analyzing data from various sources concludes that between the year 2005 and 2015 common investors in healthcare continuum - including acute care hospitals, post-acute care, hospice, etc - increased from 25% to 49%. The prevalence of common investor ownership structures within healthcare delivery systems and their evolution has not been widely noted or examined until recently. Understanding this type of investor sharing across health delivery systems is important because it inevitably affects antitrust, payment, and regulatory policies.
